Vanda Pharmaceuticals
VNDA
VNDA
179 hedge funds and large institutions have $1.18B invested in Vanda Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 69 increasing their positions, 62 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 187 → 179 (-8)
30% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 23
Holders
179
Holding in Top 10
2
Calls
$2.54M
Puts
$2.2M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$12.4M | |
| 3 | +$11.4M | |
| 4 |
Bank of New York Mellon
New York
|
+$10.9M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$9.06M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$10.5M | |
| 3 | -$9.92M | |
| 4 |
Renaissance Technologies
New York
|
-$8.08M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.48M |